Literature DB >> 21789646

Laparoscopic Dor versus Toupet fundoplication following Heller myotomy for achalasia: results of a multicenter, prospective, randomized-controlled trial.

Arthur Rawlings1, Nathaniel J Soper, Brant Oelschlager, Lee Swanstrom, Brent D Matthews, Carlos Pellegrini, Richard A Pierce, Aurora Pryor, Valeria Martin, Margaret M Frisella, Maria Cassera, L Michael Brunt.   

Abstract

BACKGROUND: The type of fundoplication that should be performed in conjunction with Heller myotomy for esophageal achalasia is controversial. We prospectively compared anterior fundoplication (Dor) with partial posterior fundoplication (Toupet) in patients undergoing laparoscopic Heller myotomy.
METHODS: A multicenter, prospective, randomized-controlled trial was initiated to compare Dor versus Toupet fundoplication after laparoscopic Heller myotomy. Outcome measures were symptomatic GERD scores (0-4, five-point Likert scale questionnaire) and 24-h pH testing at 6-12 months after surgery. Data are mean ± SD. Statistical analysis was by Mann-Whitney U test, Wilcoxon signed rank test, and Freidman's test.
RESULTS: Sixty of 85 originally enrolled and randomized patients who underwent 36 Dor and 24 Toupet fundoplications had follow-up data per protocol for analysis. Dor and Toupet groups were similar in age (46.8 vs. 51.7 years) and gender (52.8 vs. 62.5% male). pH studies at 6-12 months in 43 patients (72%: Dor n = 24 and Toupet n = 19) showed total DeMeester scores and % time pH < 4 were not significant between the two groups. Abnormal acid reflux was present in 10 of 24 Dor group patients (41.7%) and in 4 of 19 Toupet patients (21.0%) (p = 0.152). Dysphagia and regurgitation symptom scores improved significantly in both groups compared to preoperative scores. No significant differences in any esophageal symptoms were noted between the two groups preoperatively or at follow-up. SF-36 quality-of-life measures changed significantly from pre- to postoperative for five of ten domains in the Dor group and seven of ten in the Toupet patients (not significant between groups).
CONCLUSION: Laparoscopic Heller myotomy provides significant improvement in dysphagia and regurgitation symptoms in achalasia patients regardless of the type of partial fundoplication. Although a higher percentage of patients in the Dor group had abnormal 24-h pH test results compared to those of patients who underwent Toupet, the differences were not statistically significant.

Entities:  

Mesh:

Year:  2011        PMID: 21789646     DOI: 10.1007/s00464-011-1822-y

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  29 in total

1.  Long-term effect of total fundoplication on the myotomized esophagus.

Authors:  P Topart; C Deschamps; R Taillefer; A Duranceau
Journal:  Ann Thorac Surg       Date:  1992-12       Impact factor: 4.330

2.  Laparoscopic Heller myotomy with Toupet fundoplication: outcomes predictors in 121 consecutive patients.

Authors:  Yashodhan S Khajanchee; Shalini Kanneganti; Amy E B Leatherwood; Paul D Hansen; Lee L Swanström
Journal:  Arch Surg       Date:  2005-09

Review 3.  Fundoplication after laparoscopic Heller myotomy for esophageal achalasia: what type?

Authors:  Marco G Patti; Fernando A Herbella
Journal:  J Gastrointest Surg       Date:  2010-03-19       Impact factor: 3.452

4.  Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience.

Authors:  Giovanni Zaninotto; Mario Costantini; Christian Rizzetto; Lisa Zanatta; Emanuela Guirroli; Giuseppe Portale; Loredana Nicoletti; Francesco Cavallin; Giorgio Battaglia; Alberto Ruol; Ermanno Ancona
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

5.  Randomized controlled trial of laparoscopic Heller myotomy plus Dor fundoplication versus Nissen fundoplication for achalasia: long-term results.

Authors:  Fabrizio Rebecchi; Claudio Giaccone; Eleonora Farinella; Roberto Campaci; Mario Morino
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

6.  Patterns of esophageal acid exposure after laparoscopic Heller's myotomy and Dor's fundoplication for esophageal achalasia.

Authors:  John Tsiaoussis; George Pechlivanides; Nikolaos Gouvas; Elias Athanasakis; Nikolaos Zervakis; Apostolos Manitides; Evaghelos Xynos
Journal:  Surg Endosc       Date:  2007-12-20       Impact factor: 4.584

Review 7.  Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis.

Authors:  Guilherme M Campos; Eric Vittinghoff; Charlotte Rabl; Mark Takata; Michael Gadenstätter; Feng Lin; Ruxandra Ciovica
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

8.  Results of laparoscopic Heller myotomy without anti-reflux procedure in achalasia. Monocentric prospective study of 106 cases.

Authors:  M Robert; G Poncet; F Mion; J Boulez
Journal:  Surg Endosc       Date:  2007-10-18       Impact factor: 4.584

9.  Long-term outcomes confirm the superior efficacy of extended Heller myotomy with Toupet fundoplication for achalasia.

Authors:  A S Wright; C W Williams; C A Pellegrini; B K Oelschlager
Journal:  Surg Endosc       Date:  2007-03-01       Impact factor: 3.453

10.  An anterior or posterior approach to partial fundoplication? Long-term results of a randomized trial.

Authors:  C Engström; H Lönroth; J Mardani; L Lundell
Journal:  World J Surg       Date:  2007-04-24       Impact factor: 3.282

View more
  78 in total

1.  SAGES guidelines for the surgical treatment of esophageal achalasia.

Authors:  Dimitrios Stefanidis; William Richardson; Timothy M Farrell; Geoffrey P Kohn; Vedra Augenstein; Robert D Fanelli
Journal:  Surg Endosc       Date:  2011-11-02       Impact factor: 4.584

Review 2.  Data analyses and perspectives on laparoscopic surgery for esophageal achalasia.

Authors:  Kazuto Tsuboi; Nobuo Omura; Fumiaki Yano; Masato Hoshino; Se-Ryung Yamamoto; Shunsuke Akimoto; Takahiro Masuda; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

3.  Revisional surgery after failed esophagogastric myotomy for achalasia: successful esophageal preservation.

Authors:  Benjamin R Veenstra; Ross F Goldberg; Steven P Bowers; Mathew Thomas; Ronald A Hinder; C Daniel Smith
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

4.  Laparoscopic limited Heller myotomy without anti-reflux procedure does not induce significant long-term gastroesophageal reflux.

Authors:  L C Zurita Macías Valadez; R Pescarus; T Hsieh; L Wasserman; I Apriasz; D Hong; S Gmora; M Cadeddu; M Anvari
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

Review 5.  Endoscopic and Surgical Treatments for Achalasia: Who to Treat and How?

Authors:  Romulo A Fajardo; Roman V Petrov; Charles T Bakhos; Abbas E Abbas
Journal:  Gastroenterol Clin North Am       Date:  2020-06-26       Impact factor: 3.806

Review 6.  Current status in the treatment options for esophageal achalasia.

Authors:  Seng-Kee Chuah; Chien-Hua Chiu; Wei-Chen Tai; Jyong-Hong Lee; Hung-I Lu; Chi-Sin Changchien; Ping-Huei Tseng; Keng-Liang Wu
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

7.  An Overview of Achalasia and Its Subtypes.

Authors:  Dhyanesh A Patel; Brian M Lappas; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-07

8.  Tailoring Therapy for Achalasia.

Authors:  Joel E Richter
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-05

9.  Comparison of esophagogastric junction distensibility changes during POEM and Heller myotomy using intraoperative FLIP.

Authors:  Ezra N Teitelbaum; Lubomyr Boris; Fahd O Arafat; Frédéric Nicodème; Zhiyue Lin; Peter J Kahrilas; John E Pandolfino; Nathaniel J Soper; Eric S Hungness
Journal:  Surg Endosc       Date:  2013-09-17       Impact factor: 4.584

10.  Symptomatic and physiologic outcomes one year after peroral esophageal myotomy (POEM) for treatment of achalasia.

Authors:  Ezra N Teitelbaum; Nathaniel J Soper; Byron F Santos; Fahd O Arafat; John E Pandolfino; Peter J Kahrilas; Ikuo Hirano; Eric S Hungness
Journal:  Surg Endosc       Date:  2014-06-18       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.